96 related articles for article (PubMed ID: 11061491)
21. Effective treatment of experimental DU-145 prostate cancers with targeted cytotoxic somatostatin analog AN-238.
Plonowski A; Schally AV; Nagy A; Sun B; Halmos G
Int J Oncol; 2002 Feb; 20(2):397-402. PubMed ID: 11788908
[TBL] [Abstract][Full Text] [Related]
22. Investigation of cancer cell lines for peptide receptor-targeted drug development.
Sun L; Luo J; Mackey LV; Morris LM; Franko-Tobin LG; LePage KT; Coy DH
J Drug Target; 2011 Sep; 19(8):719-30. PubMed ID: 21830941
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical detection of somatostatin receptor subtypes sst1 and sst2A in human somatostatin receptor positive tumors.
Hofland LJ; Liu Q; Van Koetsveld PM; Zuijderwijk J; Van Der Ham F; De Krijger RR; Schonbrunn A; Lamberts SW
J Clin Endocrinol Metab; 1999 Feb; 84(2):775-80. PubMed ID: 10022452
[TBL] [Abstract][Full Text] [Related]
24. Expression and coupling of somatostatin receptors in rat adrenal (PC12) and pituitary (GC) cell lines.
Traina G; Lanneau C; Arnoux A; Porokhov B; Bagnoli P; Epelbaum J
Neurosci Lett; 1998 Aug; 252(2):131-4. PubMed ID: 9756339
[TBL] [Abstract][Full Text] [Related]
25. New pansomatostatin ligands and their chelated versions: affinity profile, agonist activity, internalization, and tumor targeting.
Ginj M; Zhang H; Eisenwiener KP; Wild D; Schulz S; Rink H; Cescato R; Reubi JC; Maecke HR
Clin Cancer Res; 2008 Apr; 14(7):2019-27. PubMed ID: 18381940
[TBL] [Abstract][Full Text] [Related]
26. Effect of somatostatin on nitric oxide production in human retinal pigment epithelium cell cultures.
Vasilaki A; Papadaki T; Notas G; Kolios G; Mastrodimou N; Hoyer D; Tsilimbaris M; Kouroumalis E; Pallikaris I; Thermos K
Invest Ophthalmol Vis Sci; 2004 May; 45(5):1499-506. PubMed ID: 15111608
[TBL] [Abstract][Full Text] [Related]
27. sst1 mRNA is the prominent somatostatin receptor mRNA in the rat gastrointestinal tract: reverse transcription polymerase chain reaction and in situ-hybridization study.
Schäfer J; Meyerhof W
Neuropeptides; 1999 Dec; 33(6):457-63. PubMed ID: 10657524
[TBL] [Abstract][Full Text] [Related]
28. The inhibitory effect of a novel cytotoxic somatostatin analogue AN-162 on experimental glioblastoma.
Pozsgai E; Schally AV; Halmos G; Rick F; Bellyei S
Horm Metab Res; 2010 Oct; 42(11):781-6. PubMed ID: 20665426
[TBL] [Abstract][Full Text] [Related]
29. Effective treatment of H838 human non-small cell lung carcinoma with a targeted cytotoxic somatostatin analog, AN-238.
Szereday Z; Schally AV; Szepeshazi K; Bajo AM; Hebert F; Halmos G; Nagy A
Int J Oncol; 2003 May; 22(5):1141-6. PubMed ID: 12684683
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of receptors for somatostatin in various tumors using different analogs.
Srkalovic G; Cai RZ; Schally AV
J Clin Endocrinol Metab; 1990 Mar; 70(3):661-9. PubMed ID: 1968467
[TBL] [Abstract][Full Text] [Related]
31. RT-PCR and immunocytochemistry studies support the presence of somatostatin, cortistatin and somatostatin receptor subtypes in rat Kupffer cells.
Xidakis C; Mastrodimou N; Notas G; Renieri E; Kolios G; Kouroumalis E; Thermos K
Regul Pept; 2007 Oct; 143(1-3):76-82. PubMed ID: 17481746
[TBL] [Abstract][Full Text] [Related]
32. Somatostatin receptor genes are expressed in lymphocytes from retroorbital tissues in Graves' disease.
Pasquali D; Notaro A; Bonavolonta' G; Vassallo P; Bellastella A; Sinisi AA
J Clin Endocrinol Metab; 2002 Nov; 87(11):5125-9. PubMed ID: 12414882
[TBL] [Abstract][Full Text] [Related]
33. Targeting triple-negative breast cancer through the somatostatin receptor with the new cytotoxic somatostatin analogue AN-162 [AEZS-124].
Seitz S; Buchholz S; Schally AV; Jayakumar AR; Weber F; Papadia A; Rick FG; Szalontay L; Treszl A; Köster F; Ortmann O; Hohla F
Anticancer Drugs; 2013 Feb; 24(2):150-7. PubMed ID: 23080077
[TBL] [Abstract][Full Text] [Related]
34. Growth inhibition of experimental non-Hodgkin's lymphomas with the targeted cytotoxic somatostatin analogue AN-238.
Keller G; Engel JB; Schally AV; Nagy A; Hammann B; Halmos G
Int J Cancer; 2005 May; 114(5):831-5. PubMed ID: 15609311
[TBL] [Abstract][Full Text] [Related]
35. Targeted cytotoxic somatostatin analog AN-162 inhibits growth of human colon carcinomas and increases sensitivity of doxorubicin resistant murine leukemia cells.
Hohla F; Buchholz S; Schally AV; Krishan A; Rick FG; Szalontay L; Papadia A; Halmos G; Koster F; Aigner E; Datz C; Seitz S
Cancer Lett; 2010 Aug; 294(1):35-42. PubMed ID: 20156671
[TBL] [Abstract][Full Text] [Related]
36. Fish somatostatin sst3 receptor: comparison of radioligand and GTPgammaS binding, adenylate cyclase and phospholipase C activities reveals different agonist-dependent pharmacological signatures.
Siehler S; Nunn C; Zupanc GK; Hoyer D
Auton Autacoid Pharmacol; 2005 Jan; 25(1):1-16. PubMed ID: 15659149
[TBL] [Abstract][Full Text] [Related]
37. Modulation of pituitary somatostatin receptor subtype (sst1-5) messenger ribonucleic acid levels by changes in the growth hormone axis.
Park S; Kamegai J; Johnson TA; Frohman LA; Kineman RD
Endocrinology; 2000 Oct; 141(10):3556-63. PubMed ID: 11014208
[TBL] [Abstract][Full Text] [Related]
38. Estrogen regulates somatostatin receptor subtype 2 messenger ribonucleic acid expression in human breast cancer cells.
Xu Y; Song J; Berelowitz M; Bruno JF
Endocrinology; 1996 Dec; 137(12):5634-40. PubMed ID: 8940394
[TBL] [Abstract][Full Text] [Related]
39. Cloning and expression of a human somatostatin-14-selective receptor variant (somatostatin receptor 4) located on chromosome 20.
Demchyshyn LL; Srikant CB; Sunahara RK; Kent G; Seeman P; Van Tol HH; Panetta R; Patel YC; Niznik HB
Mol Pharmacol; 1993 Jun; 43(6):894-901. PubMed ID: 8100352
[TBL] [Abstract][Full Text] [Related]
40. Loss of sst2 somatostatin receptor gene expression in human pancreatic and colorectal cancer.
Buscail L; Saint-Laurent N; Chastre E; Vaillant JC; Gespach C; Capella G; Kalthoff H; Lluis F; Vaysse N; Susini C
Cancer Res; 1996 Apr; 56(8):1823-7. PubMed ID: 8620499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]